ClinicalTrialsFinder

HPV-Related Intraepithelial Neoplasia Clinical Trials in Nanning, Guangxi

1 recruitingNanning, Guangxi, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

HPV-Related CarcinomaHPV InfectionGenital Wart+1 more
Shanghai Bovax Biotechnology Co., Ltd.330 enrolled1 locationNCT06756269